{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:30:34Z","timestamp":1793478634035,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004572","name":"National Health Commission of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004572","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jtct.2026.08.033","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T23:11:19Z","timestamp":1787267479000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Novel Conditioning Regimen Incorporating Low-Dose Cyclophosphamide and Thiotepa for Haploidentical Hematopoietic Stem Cell Transplantation in Pediatric Patients with Severe Aplastic Anemia at High Risk of Cardiotoxicity"],"prefix":"10.1016","author":[{"given":"Feng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-Hua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Xi","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2894-9034","authenticated-orcid":false,"given":"Yi-Fei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jtct.2026.08.033_bib0001","article-title":"Treatment of newly diagnosed severe aplastic anemia in children: evidence-based recommendations","volume":"71","author":"Shimano","year":"2024","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"10.1016\/j.jtct.2026.08.033_bib0002","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.3324\/haematol.2022.280758","article-title":"Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a national registry-based study","volume":"107","author":"Xu","year":"2022","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.033_bib0003","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14514","article-title":"A modified conditioning regimen based on low-dose cyclophosphamide and fludarabine for haploidentical hematopoietic stem cell transplant in severe aplastic anemia patients at risk of severe cardiotoxicity","volume":"36","author":"Lin","year":"2022","journal-title":"Clin Transplant"},{"issue":"10","key":"10.1016\/j.jtct.2026.08.033_bib0004","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/s41409-019-0509-1","article-title":"Incidence and predictors of severe cardiotoxicity in patients with severe aplastic anaemia after haploidentical haematopoietic stem cell transplantation","volume":"54","author":"Xu","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2026.08.033_bib0005","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00277-016-2654-6","article-title":"The clinical features of fatal cyclophosphamide-induced cardiotoxicity in a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT)","volume":"95","author":"Ishida","year":"2016","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1016\/j.jtct.2026.08.033_bib0006","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1111\/ajco.13674","article-title":"Cyclophosphamide-induced cardiotoxicity at conditioning for allogeneic hematopoietic stem cell transplantation would occur among the patients treated with 120 mg\/kg or less","volume":"18","author":"Marumo","year":"2022","journal-title":"Asia Pac J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.033_bib0007","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41409-022-01876-3","article-title":"Thiotepa-based reduced toxicity conditioning in combination with post-transplant cyclophosphamide and mTOR inhibitor for heavily transfused acquired severe aplastic anemia in children and young adults: encouraging outcomes of a pilot study","volume":"58","author":"Kharya","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jtct.2026.08.033_bib0008","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","article-title":"Regimen-related toxicity in patients undergoing bone marrow transplantation","volume":"6","author":"Bearman","year":"1988","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.033_bib0009","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/bmt.2016.281","article-title":"Haploidentical transplantation for pediatric patients with acquired severe aplastic anemia","volume":"52","author":"Xu","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.033_bib0010","doi-asserted-by":"crossref","first-page":"e13179","DOI":"10.1111\/ctr.13179","article-title":"First-line choice for severe aplastic anemia in children: transplantation from a haploidentical donor vs immunosuppressive therapy","volume":"32","author":"Cheng","year":"2018","journal-title":"Clin Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2026.08.033_bib0011","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41409-024-02419-8","article-title":"Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group","volume":"59","author":"Xu","year":"2024","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2026.08.033_bib0012","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s00277-024-05787-9","article-title":"Risk factors and survival outcomes in children with early cardiotoxicity after allogeneic hematopoietic stem cell transplantation","volume":"103","author":"Tong","year":"2024","journal-title":"Ann Hematol"},{"issue":"12","key":"10.1016\/j.jtct.2026.08.033_bib0013","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/s41409-024-02414-z","article-title":"Cardiac events occurring after allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide. Study conducted on behalf of the GETH-TC","volume":"59","author":"Salas","year":"2024","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2026.08.033_bib0014","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/ejh.13825","article-title":"Busulfan and cyclophosphamide-based conditioning regimen still holds the promise of being a safe and efficacious regimen for allogeneic transplantation in patients with transfusion-dependent thalassemia, even in high risk","volume":"109","author":"Mehta","year":"2022","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1016\/j.jtct.2026.08.033_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2025.12.942","article-title":"Novel FABT-based conditioning regimen with haploidentical transplantation for severe aplastic anemia: a prospective, single-center, phase II clinical trial","volume":"32","author":"Liu","year":"2026","journal-title":"Transplant Cell Ther"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.033_bib0016","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jaccao.2021.02.011","article-title":"Early cardiac toxicity associated with post-transplant cyclophosphamide in allogeneic stem cell transplantation","volume":"3","author":"Dulery","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"25","key":"10.1016\/j.jtct.2026.08.033_bib0017","first-page":"3031","article-title":"Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia","volume":"141","author":"DeZern","year":"2023","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jtct.2026.08.033_bib0018","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1038\/s41409-020-0897-2","volume":"55","author":"ElGohary","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jtct.2026.08.033_bib0019","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1097\/TP.0000000000002200","article-title":"Therapeutic outcomes of haploidentical allogeneic hematopoietic stem cell transplantation in patients with severe aplastic anemia: a multicenter study","volume":"102","author":"Li","year":"2018","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.jtct.2026.08.033_bib0020","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.bbmt.2018.05.015","article-title":"Unmanipulated haploidentical hematopoietic stem cell transplantation achieved outcomes comparable with matched unrelated donor transplantation in young acquired severe aplastic anemia","volume":"24","author":"Lu","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2026.08.033_bib0021","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/bmt.2016.347","article-title":"Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results","volume":"52","author":"Liu","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2026.08.033_bib0022","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/bmt.2015.20","article-title":"Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study","volume":"50","author":"Esteves","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2026.08.033_bib0023","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/s41409-019-0773-0","article-title":"Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT severe aplastic anemia working party","volume":"55","author":"Prata","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2026.08.033_bib0024","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/bloodadvances.2020001729","article-title":"Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide","volume":"4","author":"DeZern","year":"2020","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.jtct.2026.08.033_bib0025","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000952","article-title":"Thiotepa-busulfan-fludarabine compared to treosulfan-based conditioning for haploidentical transplant with posttransplant cyclophosphamide in patients with acute myeloid leukemia in remission: a study from the acute leukemia working party of the EBMT","volume":"7","author":"Saraceni","year":"2023","journal-title":"Hemasphere"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.033_bib0026","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13626","article-title":"Skin toxicity following treosulfan-thiotepa-fludarabine-based conditioning regimen in non-malignant pediatric patients undergoing hematopoietic stem cell transplantation","volume":"24","author":"Even-Or","year":"2020","journal-title":"Pediatr Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2026.08.033_bib0027","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s12185-016-2106-z","article-title":"Analysis of allogeneic hematopoietic stem cell transplantation with high-dose cyclophosphamide-induced immune tolerance for severe aplastic anemia","volume":"104","author":"Guo","year":"2016","journal-title":"Int J Hematol"},{"issue":"6","key":"10.1016\/j.jtct.2026.08.033_bib0028","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3345\/kjp.2015.58.6.199","article-title":"Haploidentical hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia","volume":"58","author":"Im","year":"2015","journal-title":"Korean J Pediatr"},{"issue":"8","key":"10.1016\/j.jtct.2026.08.033_bib0029","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/bmt.2017.62","article-title":"The injured heart: early cardiac effects of hematopoietic stem cell transplantation in children and young adults","volume":"52","author":"Rotz","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2026.08.033_bib0030","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14784","article-title":"The role of donor type and pre-transplant immunosuppression on outcomes of hematopoietic stem cell transplantation in children and young adults with severe aplastic anemia","volume":"28","author":"Kashif","year":"2024","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jtct.2026.08.033_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1384640","article-title":"Comparison of upfront haploidentical hematopoietic stem cell transplantation and salvage haploidentical hematopoietic stem cell transplantation after immunosuppressive therapy in children with acquired severe aplastic anemia\u2014a multicenter study","volume":"15","author":"Luo","year":"2024","journal-title":"Front Immunol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726006755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726006755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:10:41Z","timestamp":1793477441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726006755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":31,"alternative-id":["S2666636726006755"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.08.033","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Novel Conditioning Regimen Incorporating Low-Dose Cyclophosphamide and Thiotepa for Haploidentical Hematopoietic Stem Cell Transplantation in Pediatric Patients with Severe Aplastic Anemia at High Risk of Cardiotoxicity","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.08.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}